Women with Parkinson’s disease experience more and worse pain than men with the neurodegenerative condition, according to a new study that highlights sex differences in the prevalence and severity of these symptoms. Chronic pain, pain related to motor symptom fluctuations, mouth/face (oro-facial) pain, and discoloration/swelling were all more prevalent…

There are days when I feel miserable. They run together like the constant pounding of ocean waves, shaking me with constant pain. The misery is not only in my body, but also my mind — a world of exaggerated pain signal perceptions that defines too much of my life. The…

I lost most of my vision two years ago and became legally blind. It was devastating. Through the course of rehabilitation with a low vision clinic, I was taught how to see in a very new way, called eccentric viewing. Eccentric viewing is a method by which a…

My previous columns about pain and chronic pain seem to have fallen a bit short for my liking. So, following are some commonsense tips that I use when medically appropriate. I hope they help you as they’ve helped me. Tip 1: I exercise. It may seem counterintuitive…

For 15 years, I have been a failure at managing my chronic pain. I was prescribed oxycodone with gabapentin, and after my Parkinson’s diagnosis, I was put on levodopa. This decreased my pain to the point where oxycodone was no longer needed. I also tried alcohol and marijuana in a…

If you asked me what is the hardest part of having Parkinson’s disease, I might have to say the pain — today, at least. PD is so unpredictable. As it changes from day to day, moment by moment, second by second, sometimes you don’t know what to…

Life is tough for people with a chronic illness, but through the pain and the fatigue and all the other symptoms and side effects, they show an extraordinary passion for life and try to achieve as much as possible. With help from themighty.com, we’ve compiled a list of eight remarkable things…

In a recent paper published in The Lancet Neurology, researchers evaluated the analgesic effect of prolonged-release oxycodone-naloxone (OXN PR) in patients with Parkinson’s disease (PD) suffering from severe and chronic pain in a pioneer Phase II clinical trial. Pain is a very common, non-motory symptom in PD patients (approximately 60% of patients)…